Abstract:Previous studies have investigated the association between HOXA13 and non-small cell lung cancer. However, the role of HOXA13 expression in the occurrence and progression of lung adenocarcinoma (LUAD) has not yet been investigated. In the present study, HOXA13-related data mining of The Cancer Genome Atlas (TCGA), polymerase chain reaction (PCR) data from our cases and the case information in Oncomine was conducted for validation. The expression data of HOXA13 in lung cancer cell lines were also collected from the Cancer Cell Line Encyclopedia (CCLE) database for further verification. A comprehensive meta-analysis of the expression of HOXA13 was also performed, integrating the data of TCGA, in-house PCR and Oncomine. Genes that were co-expressed with HOXA13 were subsequently identified through cBioPortal and Multi Experiment Matrix (MEM), and the potential role and mechanism of HOXA13 in LUAD was investigated. The expression value of HOXA13 in the LUAD group, which comprised 237 cases, was 3.74±2.694, significantly higher than its expression value in the non-cancerous group (0.92±0.608, P<0.001). The pooled SMD for HOXA13 was 0.346 (95% CI, 0.052-0.640; P=0.068; I2=51.3%; P=0.021), The meta-analysis of diagnostic tests revealed that the area under the summary receiver operating characteristic curve (SROC) was 0.78 (95% CI, 0.75-0.82). The results demonstrated that HOXA13 is highly expressed in LUAD. In addition to the studies on HOXA13 expression in tissues, the expression data of HOXA13 in lung cancer cell lines were also collected from the CCLE database for further verification of these conclusions. Genes that were co-expressed with HOXA13 were identified for pathway analysis. The most enriched Gene Ontology terms in the genes co-expressed with HOXA13 were positive regulation of transcription from RNA polymerase II promoter, signal transduction and positive regulation of GTPase activity in biological process; cytoplasm, integral component of membrane and plasma membrane in cellular component; and significantly involved in protein binding, transcription factor activity, sequence-specific DNA binding and sequence-specific DNA binding in molecular function. Kyoto Encyclopedia of Genes and Genomes analysis revealed that these target genes were clearly involved in Pathways in cancer, Proteoglycans in cancer and cAMP signaling pathway. The hub genes obtained from the four protein-protein interaction networks were associated with HOXA13. The results of the bioinformatics research in the present study revealed that HOXA13 may influence the expression of these hub genes in such a way as to promote the occurrence and development of LUAD. In conclusion, the expression of HOXA13 in patients with LUAD and its potential clinical value were analyzed comprehensively in the present study using data from a variety of sources. Through bioinformatics analysis, evidence that HOXA13 may promote the occurrence and development of LUAD was obtained.

Comprehensive Clinical Implications of Homeobox A10 in 3,199 Cases of Non-Small Cell Lung Cancer Tissue Samples Combining Qrt-Pcr, RNA Sequencing and Microarray Data.

Identification of Key Genes and Evaluation of Clinical Outcomes in Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis

Upregulation of HOXA1 Promotes Tumorigenesis and Development of Non‑small Cell Lung Cancer: A Comprehensive Investigation Based on Reverse Transcription-Quantitative Polymerase Chain Reaction and Bioinformatics Analysis.

Upregulation Of Hoxa13 As A Potential Tumorigenesis And Progression Promoter Of Lusc Based On Qrt-Pcr And Bioinformatics

Downregulation of HOXA3 in Lung Adenocarcinoma and Its Relevant Molecular Mechanism Analysed by RT-qPCR, TCGA and in Silico Analysis

Upregulation of HOXA11 during the progression of lung adenocarcinoma detected via multiple approaches

Exploring the prognosis value, immune correlation, and drug responsiveness prediction of homeobox C6 (HOXC6) in lung adenocarcinoma

The Expression of HOXA13 in Lung Adenocarcinoma and Its Clinical Significance: A Study Based on the Cancer Genome Atlas, Oncomine and Reverse Transcription-Quantitative Polymerase Chain Reaction

Upregulation of HOXA10 Protein Expression Predicts Poor Prognosis for Colorectal Cancer.

Expression Landscape and Functional Roles of HOXA4 and HOXA5 in Lung Adenocarcinoma

MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip

HOXA5 Indicates Poor Prognosis and Suppresses Cell Proliferation by Regulating P21 Expression in Non Small Cell Lung Cancer

HOXA10 is Overexpressed in Human Ovarian Clear Cell Adenocarcinoma and Correlates with Poor Survival.

Survival Outcome and Clinicopathologicl Analysis of Homeobox Gene Cluster-Embedded LncRNAs in Human Cancers: A Systematic Review and Meta-analysis

Clinical Significance and Effect of Lncrna HOXA11-AS in NSCLC: A Study Based on Bioinformatics, in Vitro and in Vivo Verification

Overexpression of HOXA10 Promotes Gastric Cancer Cells Proliferation and HOXA10+/CD44+ is Potential Prognostic Biomarker for Gastric Cancer

UbcH10 expression provides a useful tool for the prognosis and treatment of non-small cell lung cancer

Comprehensive analysis of a homeobox family gene signature in clear cell renal cell carcinoma with regard to prognosis and immune significance

Homeobox-A13 Acts As a Functional Prognostic and Diagnostic Biomarker Via Regulating P53 and Wnt Signaling Pathways in Lung Cancer.

HOXC11 Drives Lung Adenocarcinoma Progression Through Transcriptional Regulation of SPHK1.

Evaluation of the HOXA11 Level in Patients with Lung Squamous Cancer and Insights into Potential Molecular Pathways Via Bioinformatics Analysis